Merck Keytruda with Eisai’s Lenvima succeeds in late-stage trial for liver cancer Source: Seekingalpha
Browsing: cancer
Arcus up 4% following Merck Welireg kidney cancer data Source: Seekingalpha
GSK, iTeos lung cancer therapy outperforms Jemperli in mid-stage trial Source: Seekingalpha
Merck Keytruda cuts mortality risk in gastric cancer by 20% Source: Seekingalpha
ibreakstock/iStock by way of Getty Images New information on Incyte’s (NASDAQ:INCY) Zynyz (retifanlimab) confirmed that the monoclonal antibody added to plain chemotherapy led to improved progession-free…
Merck Keytruda cuts mortality risk by 33% in late-stage trial for cervical cancer Source: Seekingalpha
Merck Keytruda with Eisai’s Lenvima succeeds in late-stage trial for liver cancer Source: Seekingalpha
Arcus up 4% following Merck Welireg kidney cancer data Source: Seekingalpha
OGphoto/iStock by way of Getty Images Shares of Arcus Biosciences (NYSE:RCUS) are up 4% in Friday afternoon buying and selling after Merck (MRK) data on its…
hapabapa Moderna (NASDAQ:MRNA) is planning to launch a messenger-RNA-based vaccine for skin cancer as early as subsequent yr, Japanese enterprise publication Nikkei reported on Thursday, citing…